The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Administration Under Fasting Conditions

NCT04012307 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Candesartan Cilexetil 32mg
DRUG: Atacand® PROTECT

Sponsor

Pharmtechnology LLC

Collaborators

[object Object]